22 related articles for article (PubMed ID: 2614081)
1. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.
Kalofonos HP; Pawlikowska TR; Hemingway A; Courtenay-Luck N; Dhokia B; Snook D; Sivolapenko GB; Hooker GR; McKenzie CG; Lavender PJ
J Nucl Med; 1989 Oct; 30(10):1636-45. PubMed ID: 2795204
[TBL] [Abstract][Full Text] [Related]
2. Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.
Kalofonos HP; Kosmas C; Hird V; Snook DE; Epenetos AA
Eur J Cancer; 1994; 30A(12):1842-50. PubMed ID: 7880616
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.
Zalutsky MR; Moseley RP; Coakham HB; Coleman RE; Bigner DD
Cancer Res; 1989 May; 49(10):2807-13. PubMed ID: 2469537
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalisation of testicular tumours using radiolabelled monoclonal antibody to placental alkaline phosphatase.
Kalofonos HP; Kosmas C; Pawlikowska TR; Bamias A; Snook D; Dhokia B; Sivolapenko GB; Courtenay-Luck NS; Epenetos AA
J Nucl Med Allied Sci; 1990; 34(4):294-8. PubMed ID: 2090793
[TBL] [Abstract][Full Text] [Related]
6. Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumors.
Bullard DE; Bigner DD
J Neurosurg; 1985 Jul; 63(1):2-16. PubMed ID: 2409248
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients].
Kubo O; Takakura K
Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965
[TBL] [Abstract][Full Text] [Related]
8. Glioma proteomics: status and perspectives.
Niclou SP; Fack F; Rajcevic U
J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038
[TBL] [Abstract][Full Text] [Related]
9. A preliminary study of brain gliomas with H17E2 monoclonal antibody: immunoscintigraphy and pharmacokinetics.
Skarlos DV; Malamitsi J; Sivolapenko GB; Demakopoulos N; Avgoustatos G; Koutoulidis C; Epenetos AA
Int J Biol Markers; 1989; 4(3):135-41. PubMed ID: 2614081
[TBL] [Abstract][Full Text] [Related]
10. Markers of central nervous system tumors.
Birkmayer GD
Immunol Ser; 1990; 53():317-22. PubMed ID: 2100565
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
